Synopsis
Synopsis
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. 1-(isopropoxycarbonyloxy)ethyl-7-(2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetamido)-3-methoxymethyl-8-oxo-5-thia-1-azabicyclo(4,2,0)-oct-2-ene-2-carboxylate
2. Cephalosporin 807
3. Cs 807
4. Cs-807
5. Doxef
6. U 76252
7. U-76,252
8. Vantin
1. Vantin
2. Banan
3. 87239-81-4
4. Orelox
5. Doxef
6. Cs-807
7. Simplicef
8. Otreon
9. U-76252
10. Podomexef
11. Chebi:3505
12. 2tb00a1z7n
13. Cefodox
14. Nsc-759161
15. (rs)-1-((isopropoxycarbonyl)oxy)ethyl (+)-(6r,7r)-7-(2-(2-amino-4-thiazolyl)-2-((z)-methoxyimino)acetamido)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
16. Dsstox_cid_2766
17. Dsstox_rid_76722
18. Cefpodoxime 1-(isopropyloxycarbonyloxy)ethyl Ester
19. Dsstox_gsid_22766
20. Xtum-o
21. 1-{[(propan-2-yloxy)carbonyl]oxy}ethyl (6r,7r)-7-{[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
22. 1-{[(propan-2-yloxy)carbonyl]oxy}ethyl 7beta-[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-3-(methoxymethyl)-3,4-didehydrocepham-4-carboxylate
23. Cas-87239-81-4
24. Simplicef [veterinary]
25. Unii-2tb00a1z7n
26. Orelox Paed
27. Ncgc00164598-01
28. Ncgc00183131-01
29. Mfcd00865088
30. Vantin (tn)
31. Cefpodoxime Proxetil [usan:usp:jan]
32. Schembl27071
33. Mls001401428
34. Chembl1201016
35. Dtxsid1022766
36. Cefpodoxime (as Proxetil)
37. Cefpodoxime Proxetil (jp17/usp)
38. Cefpodoxime Proxetil [jan]
39. Hms3715j22
40. Cefpodoxime Proxetil [usan]
41. Cefpodoxime Proxetil, Vantin
42. Hy-n7101
43. Cefpodoxime Proxetil [vandf]
44. Tox21_113377
45. Tox21_113428
46. Bdbm50248233
47. Cefpodoxime Proxetil [mart.]
48. S5350
49. Cefpodoxime Proxetil [usp-rs]
50. Cefpodoxime Proxetil [who-dd]
51. Akos015994692
52. Ccg-221250
53. Ks-1149
54. Nsc 759161
55. Cefpodoxime Proxetil [green Book]
56. (+-)-1-hydroxyethyl (+)-(6r,7r)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate, 7(sup 2)-(z)-(o-methyloxime), Isopropyl Carbonate (ester)
57. Cefpodoxime Proxetil [orange Book]
58. Ru-51807
59. Smr000469193
60. Cefpodoxime Proxetil [ep Monograph]
61. Cefpodoxime Proxetil [usp Impurity]
62. Cefpodoxime Proxetil [usp Monograph]
63. Cefpodoxime Proxetil For Peak Identification
64. Cs-0027614
65. C08115
66. D00920
67. Ab01209734-01
68. 239c814
69. A842048
70. Cefpodoxime Proxetil For Impurity H Identification
71. Cefpodoxime 1-(isopropoxycarbonyloxy)ethyl Ester
72. Cefpodoxime 1-(isopropoxycarbonyloxy)ethyl Ester [mi]
73. (+/-)-1-hydroxyethyl (+)-(6r,7r)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate, 7 (sup 2)-(z)-(o-methyloxime), Isopropyl Carbonate (ester)
74. (6r,7r)-1-((isopropoxycarbonyl)oxy)ethyl 7-((z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
75. (6r,7r)-7-(((2z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl)amino)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid 1-(((1-methylethoxy)carbonyl)oxy)ethyl Ester
76. 1-({[(1-methylethyl)oxy]carbonyl}oxy)ethyl (6r,7r)-7-({(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(methyloxy)imino]acetyl}amino)-3-[(methyloxy)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
77. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-(methoxymethyl)-8-oxo-, 1-(((1-methylethoxy)carbonyl)oxy)ethyl Ester, (6r-(6.alpha.,7.beta.(z)))-
78. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-(methoxymethyl)-8-oxo-, 1-(((1-methylethoxy)carbonyl)oxy)ethyl Ester, (6r-(6alpha,7beta(z)))-
79. 5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid, 7-[[(2z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-, 1-[[(1-methylethoxy)carbonyl]oxy]ethyl Ester, (6r,7r)-
| Molecular Weight | 557.6 g/mol |
|---|---|
| Molecular Formula | C21H27N5O9S2 |
| XLogP3 | 0.6 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 14 |
| Rotatable Bond Count | 13 |
| Exact Mass | 557.12501980 g/mol |
| Monoisotopic Mass | 557.12501980 g/mol |
| Topological Polar Surface Area | 235 Ų |
| Heavy Atom Count | 37 |
| Formal Charge | 0 |
| Complexity | 976 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
| 1 of 2 | |
|---|---|
| Drug Name | Cefpodoxime proxetil |
| PubMed Health | Cefpodoxime Proxetil (By mouth) |
| Drug Classes | Antibiotic |
| Drug Label | Cefpodoxime proxetil is an orally administered, extended spectrum, semi-synthetic antibiotic of the cephalosporin class. The chemical name is (RS)-1(isopropoxycarbonyloxy) ethyl (+)-(6R,7R)-7-[2-(2-amino-4-thiazolyl)-2-{(Z)methoxyimino}acetamido]-3-m... |
| Active Ingredient | Cefpodoxime proxetil |
| Dosage Form | Tablet; For suspension |
| Route | Oral |
| Strength | eq 100mg base; eq 200mg base; eq 100mg base/5ml; eq 50mg base/5ml |
| Market Status | Prescription |
| Company | Ranbaxy; Aurobindo Pharma; Sandoz; Orchid Hlthcare |
| 2 of 2 | |
|---|---|
| Drug Name | Cefpodoxime proxetil |
| PubMed Health | Cefpodoxime Proxetil (By mouth) |
| Drug Classes | Antibiotic |
| Drug Label | Cefpodoxime proxetil is an orally administered, extended spectrum, semi-synthetic antibiotic of the cephalosporin class. The chemical name is (RS)-1(isopropoxycarbonyloxy) ethyl (+)-(6R,7R)-7-[2-(2-amino-4-thiazolyl)-2-{(Z)methoxyimino}acetamido]-3-m... |
| Active Ingredient | Cefpodoxime proxetil |
| Dosage Form | Tablet; For suspension |
| Route | Oral |
| Strength | eq 100mg base; eq 200mg base; eq 100mg base/5ml; eq 50mg base/5ml |
| Market Status | Prescription |
| Company | Ranbaxy; Aurobindo Pharma; Sandoz; Orchid Hlthcare |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
GDUFA
DMF Review : Reviewed
Rev. Date : 2020-03-09
Pay. Date : 2020-01-21
DMF Number : 34502
Submission : 2020-02-17
Status : Active
Type : II
Certificate Number : CEP 2020-399 - Rev 02
Issue Date : 2025-11-19
Type : Chemical
Substance Number : 2341
Status : Valid
Registration Number : 303MF10058
Registrant's Address : No. 849 Dongjia Town, Licheng District, Jinan, Shandong, China
Initial Date of Registration : 2021-04-02
Latest Date of Registration :
NDC Package Code : 51810-052
Start Marketing Date : 2022-06-28
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Seongyi Bio Co., Ltd.
Registration Date : 2022-07-01
Registration Number : 20200618-25-A-359-12(1)
Manufacturer Name : Qilu Antibiotics Pharmaceutical Co., Ltd.
Manufacturer Address : No.849 Dongjia Town, Licheng District, Jinan, Shandong Province, China

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20076
Submission : 2006-12-26
Status : Active
Type : II
Certificate Number : R0-CEP 2013-064 - Rev 00
Issue Date : 2013-09-30
Type : Chemical
Substance Number : 2341
Status : Withdrawn by Holder
Registrant Name : Lee Sung International Co., Ltd.
Registration Date : 2014-06-11
Registration Number : 20140611-25-A-300-07
Manufacturer Name : Sandoz GmbH
Manufacturer Address : Biochemiestraβe 10, 6250 Kundl, Austria

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23572
Submission : 2010-02-23
Status : Active
Type : II
Date of Issue : 2022-05-17
Valid Till : 2025-05-16
Written Confirmation Number : WC-00008A1
Address of the Firm :

GDUFA
DMF Review : Reviewed
Rev. Date : 2017-02-27
Pay. Date : 2016-12-27
DMF Number : 29791
Submission : 2015-09-14
Status : Active
Type : II
Date of Issue : 2025-11-07
Valid Till : 2025-09-30
Written Confirmation Number : WC-0190
Address of the Firm :
NDC Package Code : 61788-5000
Start Marketing Date : 2004-05-29
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Youngjin Pharmaceutical Co., Ltd.
Registration Date : 2017-08-03
Registration Number : 20150410-25-A-305-10(1)
Manufacturer Name : Covalent Laboratories Pvt. Ltd
Manufacturer Address : Sy. No.374, Gundla Machanoor Village, Hathnoor Mandal, Sangareddy District - 502 296, Telangana State,

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18505
Submission : 2005-07-11
Status : Active
Type : II
Registration Number : 306MF10078
Registrant's Address : Plot No. 121-128, 128A-133, 138-151, 159-164, SIDCO Industrial Estate, Alathur, Chengalpattu District-603 110, Tamilnadu, INDIA.
Initial Date of Registration : 2024-06-12
Latest Date of Registration :

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16542
Submission : 2003-04-15
Status : Inactive
Type : II
Certificate Number : R1-CEP 2010-283 - Rev 01
Issue Date : 2017-12-05
Type : Chemical
Substance Number : 2341
Status : Valid
Registration Number : 225MF10129
Registrant's Address : Biochemiesstrasse 10, 6250 Kundl, Austria
Initial Date of Registration : 2013-07-09
Latest Date of Registration :
Registrant Name : HK Innoen Co., Ltd.
Registration Date : 2014-07-25
Registration Number : 20140611-25-A-300-07(1)
Manufacturer Name : Sandoz GmbH
Manufacturer Address : Biochemiestraβe 10, 6250 Kundl, Austria

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6937
Submission : 1987-04-15
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9886
Submission : 1987-04-15
Status : Inactive
Type : II

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Details:
Infex (Cefpodoxime) is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Sinusitis.
Lead Product(s): Cefpodoxime Proxetil,Inapplicable
Therapeutic Area: Otolaryngology (Ear, Nose, Throat) Brand Name: Infex
Study Phase: Phase IIIProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable November 02, 2018

Lead Product(s) : Cefpodoxime Proxetil,Inapplicable
Therapeutic Area : Otolaryngology (Ear, Nose, Throat)
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Infex (Cefpodoxime) is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Sinusitis.
Product Name : Infex
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 02, 2018

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
ETX0282 is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Lead Product(s): ETX0282,Cefpodoxime Proxetil
Therapeutic Area: Undisclosed Brand Name: Undisclosed
Study Phase: Phase IProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable April 09, 2018

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : ETX0282,Cefpodoxime Proxetil
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : ETX0282 is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
April 09, 2018

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CAS Number : 24701-69-7
End Use API : Cefpodoxime Proxetil
About The Company : Hubei Ling Sheng Pharmaceutical Co., Ltd. was established in December 29, 2010, the company is located in Xiangyang City, Hubei Province Xiangcheng Economic Dev...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Orelox
Dosage Form : Tablet
Dosage Strength : 100mg
Packaging :
Approval Date : 21-02-1992
Application Number : 1.99E+13
Regulatory Info : Deregistered
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Orelox
Dosage Form : Cefpodoxime 0.8% 100Ml Oral Use
Dosage Strength : BB os suspe grat 100 ml 40 mg/5 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Orelox
Dosage Form : Cefpodoxime 100Mg 12 Combined Oral Use
Dosage Strength : 12 cpr riv 100 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Orelox
Dosage Form : Cefpodoxime 200Mg 6 Combined Oral Use
Dosage Strength : 6 cpr riv 200 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : ORELOX
Dosage Form : Granulate For Oral Suspension
Dosage Strength : 0.80%
Packaging : 100 ML 0.8% - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : ORELOX
Dosage Form : Film-Coated Tablets
Dosage Strength : 100 mg
Packaging : 12 UNITS 100 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : ORELOX
Dosage Form : Film-Coated Tablets
Dosage Strength : 200 mg
Packaging : 6 UNITS 200 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Withdrawn
Registration Country : Malta
Brand Name : Orelox
Dosage Form : Film Coated Tablet
Dosage Strength : 100MG
Packaging :
Approval Date : 2005-10-12
Application Number :
Regulatory Info : Withdrawn
Registration Country : Malta
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Withdrawn
Registration Country : Malta
Brand Name : Orelox Children And Infants
Dosage Form : Granule For Oral Suspension
Dosage Strength : 5ML
Packaging :
Approval Date : 2005-09-28
Application Number :
Regulatory Info : Withdrawn
Registration Country : Malta
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Withdrawn
Registration Country : Malta
Brand Name : Orelox
Dosage Form : Film Coated Tablet
Dosage Strength : 200MG
Packaging :
Approval Date : 2011-05-06
Application Number :
Regulatory Info : Withdrawn
Registration Country : Malta
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code : AB
Brand Name : CEFPODOXIME PROXETIL
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 100MG BASE
Approval Date : 2007-06-11
Application Number : 65370
RX/OTC/DISCN : RX
RLD : No
TE Code : AB

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code : AB
Brand Name : CEFPODOXIME PROXETIL
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 200MG BASE
Approval Date : 2007-06-11
Application Number : 65370
RX/OTC/DISCN : RX
RLD : No
TE Code : AB

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Brand Name : CEFPODOXIME PROXETIL
Dosage Form : FOR SUSPENSION;ORAL
Dosage Strength : EQ 50MG BASE/5ML
Approval Date : 2009-01-14
Application Number : 90031
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Brand Name : CEFPODOXIME PROXETIL
Dosage Form : FOR SUSPENSION;ORAL
Dosage Strength : EQ 100MG BASE/5ML
Approval Date : 2009-01-14
Application Number : 90031
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Brand Name : BANAN
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 100MG BASE
Approval Date : 1992-08-07
Application Number : 50687
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Brand Name : BANAN
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 200MG BASE
Approval Date : 1992-08-07
Application Number : 50687
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : Yes
TE Code :
Brand Name : VANTIN
Dosage Form : FOR SUSPENSION;ORAL
Dosage Strength : EQ 100MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date : 1992-08-07
Application Number : 50675
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code : AB
Brand Name : CEFPODOXIME PROXETIL
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 100MG BASE
Approval Date : 2008-05-28
Application Number : 65462
RX/OTC/DISCN : RX
RLD : No
TE Code : AB

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code : AB
Brand Name : CEFPODOXIME PROXETIL
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 200MG BASE
Approval Date : 2008-05-28
Application Number : 65462
RX/OTC/DISCN : RX
RLD : No
TE Code : AB

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Brand Name : CEFPODOXIME PROXETIL
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 100MG BASE
Approval Date : 2003-08-20
Application Number : 65083
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Orelox
Dosage Form : Tablet
Dosage Strength : 100mg
Packaging :
Approval Date : 21-02-1992
Application Number : 1.99E+13
Regulatory Info : Deregistered
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Orelox
Dosage Form : Cefpodoxime 0.8% 100Ml Oral Use
Dosage Strength : BB os suspe grat 100 ml 40 mg/5 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Orelox
Dosage Form : Cefpodoxime 100Mg 12 Combined Oral Use
Dosage Strength : 12 cpr riv 100 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Orelox
Dosage Form : Cefpodoxime 200Mg 6 Combined Oral Use
Dosage Strength : 6 cpr riv 200 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : ORELOX
Dosage Form : Granulate For Oral Suspension
Dosage Strength : 0.80%
Packaging : 100 ML 0.8% - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : ORELOX
Dosage Form : Film-Coated Tablets
Dosage Strength : 100 mg
Packaging : 12 UNITS 100 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : ORELOX
Dosage Form : Film-Coated Tablets
Dosage Strength : 200 mg
Packaging : 6 UNITS 200 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Withdrawn
Registration Country : Malta
Brand Name : Orelox
Dosage Form : Film Coated Tablet
Dosage Strength : 100MG
Packaging :
Approval Date : 2005-10-12
Application Number :
Regulatory Info : Withdrawn
Registration Country : Malta
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Withdrawn
Registration Country : Malta
Brand Name : Orelox Children And Infants
Dosage Form : Granule For Oral Suspension
Dosage Strength : 5ML
Packaging :
Approval Date : 2005-09-28
Application Number :
Regulatory Info : Withdrawn
Registration Country : Malta
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Withdrawn
Registration Country : Malta
Brand Name : Orelox
Dosage Form : Film Coated Tablet
Dosage Strength : 200MG
Packaging :
Approval Date : 2011-05-06
Application Number :
Regulatory Info : Withdrawn
Registration Country : Malta
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Regulatory Info :
Registration Country : India
Brand Name : Cefpodoxime Proxetil
Dosage Form : Granules
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Granules
Dosage Strength : 200MG
Brand Name : Cefpodoxime Proxetil
Approval Date :
Application Number :
Registration Country : India
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : India
Cefpodoxime Proxetil; Clavulanic Acid
Brand Name : Cefpodoxime;Clavulanic...
Dosage Form : Dry Syrup
Dosage Strength : 100MG; 62.5MG
Packaging : 30ml
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging : 30ml
Regulatory Info :
Cefpodoxime Proxetil; Clavulanic Acid
Dosage : Dry Syrup
Dosage Strength : 100MG; 62.5MG
Brand Name : Cefpodoxime;Clavulanic...
Approval Date :
Application Number :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 100mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 100mg
Brand Name :
Approval Date :
Application Number :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : TABLET
Dosage Strength : 100
Packaging :
Approval Date :
Application Number : 65370
Regulatory Info : Generic
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info : Generic
Dosage : TABLET
Dosage Strength : 100
Brand Name :
Approval Date :
Application Number : 65370
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 100MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info : Generic
Dosage : Tablet
Dosage Strength : 100MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : TABLET
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info : Generic
Dosage : TABLET
Dosage Strength : 50MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : India
Cefpodoxime Proxetil; Clavulanic Acid
Brand Name : Cefpodoxime Proxetil ;...
Dosage Form : Tablet
Dosage Strength : 100 MG ; 62.50 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info :
Cefpodoxime Proxetil; Clavulanic Acid
Dosage : Tablet
Dosage Strength : 100 MG ; 62.50 MG
Brand Name : Cefpodoxime Proxetil ;...
Approval Date :
Application Number :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 200mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 200mg
Brand Name :
Approval Date :
Application Number :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 200mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 200mg
Brand Name :
Approval Date :
Application Number :
Registration Country : India

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Reply
17 Dec 2025
Reply
11 Jun 2024
Reply
03 Nov 2023
Reply
09 Jun 2023
Reply
14 Feb 2023
Reply
10 Jan 2023
Reply
30 Nov 2022
Reply
02 Jul 2022
Reply
30 Jun 2022
Reply
07 Feb 2022
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
16
PharmaCompass offers a list of Cefpodoxime Proxetil API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Cefpodoxime Proxetil manufacturer or Cefpodoxime Proxetil supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cefpodoxime Proxetil manufacturer or Cefpodoxime Proxetil supplier.
A Cefpodoximum manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cefpodoximum, including repackagers and relabelers. The FDA regulates Cefpodoximum manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cefpodoximum API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cefpodoximum manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Cefpodoximum supplier is an individual or a company that provides Cefpodoximum active pharmaceutical ingredient (API) or Cefpodoximum finished formulations upon request. The Cefpodoximum suppliers may include Cefpodoximum API manufacturers, exporters, distributors and traders.
click here to find a list of Cefpodoximum suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Cefpodoximum DMF (Drug Master File) is a document detailing the whole manufacturing process of Cefpodoximum active pharmaceutical ingredient (API) in detail. Different forms of Cefpodoximum DMFs exist exist since differing nations have different regulations, such as Cefpodoximum USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cefpodoximum DMF submitted to regulatory agencies in the US is known as a USDMF. Cefpodoximum USDMF includes data on Cefpodoximum's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cefpodoximum USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cefpodoximum suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Cefpodoximum Drug Master File in Japan (Cefpodoximum JDMF) empowers Cefpodoximum API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Cefpodoximum JDMF during the approval evaluation for pharmaceutical products. At the time of Cefpodoximum JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Cefpodoximum suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Cefpodoximum Drug Master File in Korea (Cefpodoximum KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Cefpodoximum. The MFDS reviews the Cefpodoximum KDMF as part of the drug registration process and uses the information provided in the Cefpodoximum KDMF to evaluate the safety and efficacy of the drug.
After submitting a Cefpodoximum KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Cefpodoximum API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Cefpodoximum suppliers with KDMF on PharmaCompass.
A Cefpodoximum CEP of the European Pharmacopoeia monograph is often referred to as a Cefpodoximum Certificate of Suitability (COS). The purpose of a Cefpodoximum CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Cefpodoximum EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Cefpodoximum to their clients by showing that a Cefpodoximum CEP has been issued for it. The manufacturer submits a Cefpodoximum CEP (COS) as part of the market authorization procedure, and it takes on the role of a Cefpodoximum CEP holder for the record. Additionally, the data presented in the Cefpodoximum CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Cefpodoximum DMF.
A Cefpodoximum CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Cefpodoximum CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Cefpodoximum suppliers with CEP (COS) on PharmaCompass.
A Cefpodoximum written confirmation (Cefpodoximum WC) is an official document issued by a regulatory agency to a Cefpodoximum manufacturer, verifying that the manufacturing facility of a Cefpodoximum active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Cefpodoximum APIs or Cefpodoximum finished pharmaceutical products to another nation, regulatory agencies frequently require a Cefpodoximum WC (written confirmation) as part of the regulatory process.
click here to find a list of Cefpodoximum suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cefpodoximum as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Cefpodoximum API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Cefpodoximum as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Cefpodoximum and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cefpodoximum NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Cefpodoximum suppliers with NDC on PharmaCompass.
Cefpodoximum Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cefpodoximum GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Cefpodoximum GMP manufacturer or Cefpodoximum GMP API supplier for your needs.
A Cefpodoximum CoA (Certificate of Analysis) is a formal document that attests to Cefpodoximum's compliance with Cefpodoximum specifications and serves as a tool for batch-level quality control.
Cefpodoximum CoA mostly includes findings from lab analyses of a specific batch. For each Cefpodoximum CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cefpodoximum may be tested according to a variety of international standards, such as European Pharmacopoeia (Cefpodoximum EP), Cefpodoximum JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cefpodoximum USP).